Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
The closing price of Pacific Biosciences of California Inc (NASDAQ: PACB) was $1.11 for the day, down -1.77% from the previous closing price of $1.13. In other words, the price has decreased by -$1.77 from its previous closing price. On the day, 5.26 million shares were traded.
Ratios:
Our analysis of PACB’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 6.59 and its Current Ratio is at 7.48. In the meantime, Its Debt-to-Equity ratio is 1.33 whereas as Long-Term Debt/Eq ratio is at 1.31.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 03 ’25 when HENRY CHRISTIAN O sold 12,497 shares for $1.41 per share. The transaction valued at 17,583 led to the insider holds 2,225,357 shares of the business.
Van Oene Mark sold 6,486 shares of PACB for $9,126 on Mar 03 ’25. The insider now owns 1,497,695 shares after completing the transaction at $1.41 per share. On Mar 03 ’25, another insider, Farmer Michele, who serves as the insider of the company, sold 2,973 shares for $1.41 each. As a result, the insider received 4,183 and left with 184,619 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 2.16 while its Price-to-Book (P/B) ratio in mrq is 0.65.
Stock Price History:
Over the past 52 weeks, PACB has reached a high of $2.72, while it has fallen to a 52-week low of $1.06. The 50-Day Moving Average of the stock is -12.47%, while the 200-Day Moving Average is calculated to be -33.31%.
Shares Statistics:
A total of 294.42M shares are outstanding, with a floating share count of 264.11M. Insiders hold about 11.97% of the company’s shares, while institutions hold 73.90% stake in the company.